The advantages of switch to subcutaneous bortezomib in the real life.
Leuk Lymphoma
; 59(6): 1505-1507, 2018 06.
Article
in En
| MEDLINE
| ID: mdl-28980500
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bortezomib
/
Multiple Myeloma
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Leuk Lymphoma
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2018
Document type:
Article
Affiliation country:
Italy